BioNTech Q3 2026 Earnings
-Adj EPS: €1.76 -Rev: €1.29B (est €1.02B)
-Operating Income: €125.0M
-Sees FY Rev: €1.70B To €1.90B (previously €1.60B To €1.90B)
-Still Sees FY SG&A Expense: €700M To €800M (est €761.1M)
-Still Sees FY R&D Expenses: €2.00B To €2.30B
запускает buyback на $1 млрд